165 related articles for article (PubMed ID: 36724187)
1. Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBVmax nor vessel densities correlate between newly diagnosed and progressive glioblastoma.
Steidl E; Filipski K; Hattingen E; Steinbach JP; Maurer GD
PLoS One; 2023; 18(2):e0274400. PubMed ID: 36724187
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective study.
Steidl E; Müller M; Müller A; Herrlinger U; Hattingen E
J Neurooncol; 2019 Sep; 144(2):409-417. PubMed ID: 31321614
[TBL] [Abstract][Full Text] [Related]
3. IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.
Xing Z; Zhang H; She D; Lin Y; Zhou X; Zeng Z; Cao D
Acta Radiol; 2019 Dec; 60(12):1663-1672. PubMed ID: 31084193
[TBL] [Abstract][Full Text] [Related]
4. Correlation between dynamic susceptibility contrast perfusion MRI and genomic alterations in glioblastoma.
Ozturk K; Soylu E; Cayci Z
Neuroradiology; 2021 Nov; 63(11):1801-1810. PubMed ID: 33738509
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the hypervascularized fraction of glioblastomas using a volume analysis of dynamic susceptibility contrast-enhanced MRI may help to identify pseudoprogression.
Roques M; Catalaa I; Raveneau M; Attal J; Siegfried A; Darcourt J; Cognard C; de Champfleur NM; Bonneville F
PLoS One; 2022; 17(10):e0270216. PubMed ID: 36227862
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
7. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.
Law M; Young R; Babb J; Pollack E; Johnson G
AJNR Am J Neuroradiol; 2007 Apr; 28(4):761-6. PubMed ID: 17416835
[TBL] [Abstract][Full Text] [Related]
9. Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.
Spampinato MV; Schiarelli C; Cianfoni A; Giglio P; Welsh CT; Bisdas S; Rumboldt Z
Neuroradiol J; 2013 Aug; 26(4):385-95. PubMed ID: 24007727
[TBL] [Abstract][Full Text] [Related]
10. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging.
Yang X; Xing Z; She D; Lin Y; Zhang H; Su Y; Cao D
BMC Med Imaging; 2022 May; 22(1):105. PubMed ID: 35644621
[TBL] [Abstract][Full Text] [Related]
11. Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study.
Del Mar Álvarez-Torres M; Juan-Albarracín J; Fuster-Garcia E; Bellvís-Bataller F; Lorente D; Reynés G; Font de Mora J; Aparici-Robles F; Botella C; Muñoz-Langa J; Faubel R; Asensio-Cuesta S; García-Ferrando GA; Chelebian E; Auger C; Pineda J; Rovira A; Oleaga L; Mollà-Olmos E; Revert AJ; Tshibanda L; Crisi G; Emblem KE; Martin D; Due-Tønnessen P; Meling TR; Filice S; Sáez C; García-Gómez JM
J Magn Reson Imaging; 2020 May; 51(5):1478-1486. PubMed ID: 31654541
[TBL] [Abstract][Full Text] [Related]
12. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
13. Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence.
Blasel S; Zagorcic A; Jurcoane A; Bähr O; Wagner M; Harter PN; Hattingen E
J Neuroimaging; 2016; 26(1):116-23. PubMed ID: 25907688
[TBL] [Abstract][Full Text] [Related]
14. Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab.
Hilario A; Sepulveda JM; Hernandez-Lain A; Salvador E; Koren L; Manneh R; Ruano Y; Perez-Nuñez A; Lagares A; Ramos A
Clin Transl Oncol; 2017 Jan; 19(1):51-57. PubMed ID: 27026567
[TBL] [Abstract][Full Text] [Related]
15. Can Dynamic Susceptibility Contrast Perfusion Imaging be Utilized to Detect Isocitrate Dehydrogenase Gene Mutation in Gliomas?
Kilincer A; Cebeci H; Seher N; Durmaz MS; Uysal E; Sahinoglu M; Koktekir E; Karabagli H; Karabagli P; Paksoy Y
Turk Neurosurg; 2022; 32(5):826-833. PubMed ID: 35713257
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma: Vascular Habitats Detected at Preoperative Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Survival.
Juan-Albarracín J; Fuster-Garcia E; Pérez-Girbés A; Aparici-Robles F; Alberich-Bayarri Á; Revert-Ventura A; Martí-Bonmatí L; García-Gómez JM
Radiology; 2018 Jun; 287(3):944-954. PubMed ID: 29357274
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging-derived parameters to predict response to regorafenib in recurrent glioblastoma.
Martucci M; Ferranti AM; Schimperna F; Infante A; Magnani F; Olivi A; D'Alessandris QG; Gessi M; Chiesa S; Mazzarella C; Russo R; Giordano C; Gaudino S
Neuroradiology; 2023 Oct; 65(10):1439-1445. PubMed ID: 37247021
[TBL] [Abstract][Full Text] [Related]
18. Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.
Bonekamp D; Deike K; Wiestler B; Wick W; Bendszus M; Radbruch A; Heiland S
J Magn Reson Imaging; 2015 Jul; 42(1):87-96. PubMed ID: 25244574
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of volume analysis of dynamic susceptibility contrast perfusion-weighted imaging in untreated glioblastomas.
Roques M; Raveneau M; Adam G; De Barros A; Catalaa I; Patsoura S; Cognard C; Darcourt J; Bonneville F
Neuroradiology; 2022 Sep; 64(9):1763-1771. PubMed ID: 35364709
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
